ACA
JNCE

Avoro Capital Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Avoro Capital Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-555,000
Closed -$5.7M – 50
2021
Q1 		$5.7M Buy
+555,000
New +$5.7M 0.1% 45
2018
Q2 		– Sell
-523,174
Closed -$11.7M – 56
2018
Q1 		$11.7M Buy
+523,174
New +$11.7M 0.56% 29